HDAC8 and mucositis: Butyrate, a key SCFA, has been shown to inhibit histone deacetylase 8 (HDAC8), suppress NF-κB–driven pro-inflammatory genes, and up-regulate tight junction proteins, leading to improved nutrient absorption and reduced chemotherapy-induced mucositis [35].